Combination drug explained

A combination drug is most simply defined as a chemical composition of at least two drugs combined in a single dosage form, typically as a tablet or capsule to be administered orally, an elixir or tincture (sublingual), an injectable suspension (intramuscular administration or intravenous therapy), or a suppository (rectal). A legitimate combination drug that exceeds rigorous laboratory quality standards and is approved for medical use is a safe option for treating multiple symptoms or diseases amongst various patients within a large population - and this includes combinations of over-the-counter medicine and/or of prescription drugs. When medications are paired with supplements, consumers can be certain of accurate dosing and ingredient labeling, as well as product quality as it would be regulated and manufactured as a medication and must meet rigorous standards of pharmaceutical quality.

A polypill is a pill containing four or more active ingredients,^{[1] [2]} often produced at a compounding pharmacy due to the specific dosage, dosage form, and modified release mechanism. Polypills can encompass four or more of any combination of approved prescription drugs and over the counter drugs, as well as nutritional supplements and hormones, amino acids, enzymes, vitamins, and/or essential minerals.^[3]

History

Fixed-dose combination drugs were initially developed to target a single disease, as with antiretroviral FDCs indicated for treating AIDS and HIV.^[4] Combination drug treatment conceptually emphasizes simplified treatment plans, reduced pill burden and increased patient compliance by offering accessible and affordable ingredients, generally generic drugs with established therapeutic efficacy, and the ability to treat a variety of symptoms and conditions amongst a large patient population with varying treatment needs.

Combination legend drugs

The following are generally available as legend drugs, typically availably by prescription.The combination drugs listed below are universally available by prescription only, but specific circumstances regarding a given combination's legal accessibility, or any specific regulation pertinent to ingredient quality, quantities, production standards, sourcing, etc. will vary by jurisdictions, and include:^[5]

• amitriptyline/perphenazine (Triavil), amitriptyline/chlordiazepoxide (Limbitrol-H),^{[6] [7] [8]} and Bangladesh
• amlodipine/benazepril (Lotrel), amlodipine/atorvastatin (Conduet),
• amlodipine/celecoxib (Consensai)
• lisinopril/amlodipine (Lisonorm),
• amlodipine/olmesartan
• amlodipine/valsartan (Exforge)
• amphetamine racemic salt mixture (dextroamphetamine as sulfate and saccharate, levoamphetamine as sulfate and aspartate monohydrate) (Adderall)
• bupropion/naltrexone (Contrave)
• butalbital and caffeine (Butapap); butalbital, caffeine, and either aspirin (Fiorinal) or acetaminophen (Fioricet), Fioricet with Codeine
• calcipotriol/betamethasone dipropionate, Dovobet by LEO Pharma.
• carbidopa/levodopa/entacapone (LCE), Stalevo, Lecigon for infusion therapy in some European countries
• chlordiazepoxide and clidinium bromide^{[9] [10]}
  • ephedrine/ethylmorphine flupentixol/melitracen, available in Bangladesh as Deanxit by Lundbeck
• hydrocodone/acetaminophen^[11] LorTab by UCB is now solely available as a syrup in the U.S.^[12]
• hydrocodone and aspirin, Azdone
• hydrocodone and guaifenesin (expectorant), Obedron, Flowtuss
• hydrocodone and ibuprofen (nonsteroidal anti-inflammatory]])NSAID), Ibudone
• ibuprofen and acetaminophen intravenous solution, ibuprofen/paracetamol (Maxigesic IV^[13]
• nirmatrelvir (antiviral) and ritonavir (antiviral), combination drug for treatment and management of COVID-19), Paxlovid^[14]
  • omeprazole/amoxicillin/rifabutin olanzapine/fluoxetine
• oxycodone/acetaminophen (Percocet)
• oxycodone/aspirin (Percodan)
• oxycodone/ibuprofen (Combunol)
• phentermine/topiramate (Qsymia)
• phenylephrine/ketorolac (Omidria)^[15]
• pseudoephedrine/carbinoxamine (Rondec) elixir^[16]
• Propyphenazone/paracetamol/caffeine
• tramadol/paracetamol

Combination drugs accessible over the counter

Combination drugs are sold over the counter in some countries. In the United States, products containing the active ingredient ephedrine, pseudoephedrine, or phenylpropanolamine are stored behind the pharmacy counter and can be purchased without a medical prescription, albeit subject to U.S. Federal drug law recordkeeping requirements as required by the Combat Methamphetamine Epidemic Act of 2005.^[17] The following combination drugs are accessible OTC in nearly all locations:

• aspirin/paracetamol (Anacin)^[18] and aspirin/paracetamol/caffeine (Excedrin)^[19]
• Various cough medicines combine: dextromethorphan, acetaminophen, chlorpheniramine, doxylamine succinate, phenylpropanolamine, pseudoephedrine, guaifenesin, etc. (Robitussin, Coricidin, Altec, Rondec)^{[20] [21] [22] [23]}
• diphenhydramine/dimenhydrinate (Dramamine)^{[24] [25]}
• fenproporex/diazepam (Esbelcaps), available in Central America and Paraguay; discontinued in Brazil^[26]
• fexofenadine/pseudoephedrine (Allegra-D)
• glucose/fructose/phosphoric acid (Emetrol for Nausea)
• guaifenesin/phenylephrine (Sudafed PE)
• ibuprofen/famotidine (Duexis)^[27] and ibuprofen/diphenhydramine (Advil PM); acetaminophen/diphenhydramine (Tylenol PM)
• loratadine/pseudoephedrine (Claritin-D)
• naproxen/diphenhydramine (Aleve PM)^[28] and naproxen/pseudoephedrine (Aleve-D)
• oxomemazine/guaifenesin (Toplexil by Aventis), available in France, Algeria, and Morocco^[29]

Combination drugs under development

• MDMA/citalopram, entactogen and SSRI antidepressant in Phase II clinical trials for treating post-traumatic stress disorder.^[30]

Combination drugs for veterinary use

• Temaril-P combines alimemazine (antitussive) and prednisolone (antipruritic), approved for use in dogs, generic drug since 2024, and substitutes alimemazine for trimeprazine, leaving in place prednisolone, equivalent to branded formula in efficacy
• Titzeol combines tiletamine and zolazepam, large animal tranquilizer^[31]

Widely discontinued formulations

Several fixed-dose combination drugs marketed in the mid-20th century were later withdrawn due to safety concerns, changing regulatory standards, or abuse potential. Notable examples include:

• Dexamyl – a combination of dextroamphetamine and amobarbital, used as a stimulant-sedative preparation, withdrawn in the early 1980s.
• Tuinal – a combination of two barbiturates, amobarbital and secobarbital, prescribed as a sedative and hypnotic; it became notable both for medical use and recreational abuse. * Ethobral by Wyeth combined secobarbital, butabarbital, and phenobarbital^{[32] [33]}
• Anox (Anox Diacels) – a triple barbiturate plus stimulant combination (phenobarbital, butabarbital, secobarbital, with methamphetamine and dextroamphetamine), reflecting the mid-century trend of “upper-lower” formulations.^[34]
• Fenfluramine/phentermine (fen-phen) – an appetite suppressant combination withdrawn in 1997 after reports of cardiac valve toxicity.^[35]
• Mandrax and Durophet – a combination of methaqualone and diphenhydramine, widely used recreationally in South Africa until 1993.
• Obetrol and Biphetamine – mixed amphetamine salts used historically for obesity and attention disorders.
• Eskatrol – combined dextroamphetamine with prochlorperazine, historically prescribed for appetite suppression.
• Amfecloral (dextroamphetamine/chloral hydrate) discontinued 1973^[36]
• ^[37] Obocell^{[38] [39] [40] [41]}) combined 10 mg dextroamphetamine tannate with 35 mg secobarbital^[42]

These examples illustrate a period when pharmaceutical companies marketed combination drugs to address multiple therapeutic effects simultaneously, often combining stimulants and sedatives in the same formulation. Many such products were eventually withdrawn due to safety, abuse potential, or evolving regulatory standards.^{[43] [44]}

Justification of medical use

Fixed-dose combination drugs are used to simplify treatment regimens by delivering multiple active ingredients in a single dosage form. This approach may reduce pill burden, improve medication adherence, and enhance convenience for patients with chronic conditions, though combination products also have limitations. The fixed ratio of ingredients may restrict dose adjustment for individual components, and contraindication to one constituent may preclude use of the entire product. Formulation can also present technical challenges, including compatibility, stability, and dissolution differences among active ingredients and excipients.^[45]

Illicit or informal combinations

Outside regulated pharmaceutical products, some illicit drugs are distributed or consumed as mixtures of multiple psychoactive substances. Examples include cocaine adulterated with levamisole, counterfeit opioid tablets containing fentanyl or other synthetic opioids, and “Mandrax,” a preparation combining methaqualone and diphenhydramine. Such products are not standardized and may contain unpredictable quantities of their components. The veterinary anthelmintic levamisole has been widely detected as an adulterant in cocaine supplies and has been associated with serious adverse effects such as agranulocytosis and vasculitis.^[46]

Following the closure of numerous pill mill operations in the United States beginning in the late 2000s, the illicit opioid market expanded substantially.^[47] Counterfeit tablets sold as prescription opioids are often manufactured illicitly and may contain undeclared quantities of highly potent synthetic opioids, including fentanyl, carfentanil, and nitazenes . Additional adulterants reported in illicit drug supplies include the veterinary sedative xylazine and triazolobenzodiazepines such as bromazolam or phenazolam.. Xylazine has been scheduled as a controlled substance in several U.S. states and has been considered for federal regulation.^{[48] [49] [50]} In April 2025, U.S. Attorney General Pam Bondi stated a desire to regulate xylazine under U.S. federal drug law) as a Schedule III controlled substance.^[51] Xylazine is currently a controlled substance under state statutes in Michigan and New York.^[52]

See also

• Codrugs
• Synergy#Drug synergy

Notes and References

1. Web site: 2009-04-01 . 5-in-1 PolyPill Treatment May Prevent Heart Disease . https://web.archive.org/web/20140227164714/http://www.bayviewrx.com/bayview-blog/bid/18766/5-in-1-PolyPill-Treatment-May-Prevent-Heart-Disease . 2014-02-27 . www.bayviewrx.com . Martin . Mike .
2. Web site: Cardioprotective Drugs: Polypills . Grobbee'&#93 . ['Diederick E. .
3. Web site: The Compounder - Amino Acids, Minerals, Nutrients & Vitamins .
4. Web site: Antiretroviral Drug Discovery and Development . National Institutes of Health . 5 February 2024 . 2025-04-25.
5. A. . Wilkins . Hannlie . Hamman . H. . Hamman . H. . Steenekamp . Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features . Pharmaceutics . February 2024 . 16 . 2 . 178 . 10.3390/pharmaceutics16020178 . 38399239 . 10892518 . free .
6. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016949s042lbl.pdf
7. Web site: Limbitrol for Schizoid Personality, Obsessive-Compulsive Disorder, Comulsive Decluttering, and Social Phobia . U.S. Food and Drug Administration Office of Access to Study Results . U.S. Food and Drug Administration (FDA) via www.accessfda.gov.
8. FDA info pamphlet for Limbitrol H
9. https://www.goodrx.com/librax/what-is?srsltid=AfmBOoprJz8XcQ7jc0LGipTRE_p2TymM_psQ45Vj7iptkdP1gU3lDimO GoodRX: combination is generic for Librax
10. Web site: Product information and pricing; side effects; dosage recommendations; toxic range and therapeutic window . GoodRx Discount Program: Overview of LIBRAX . GoodRx . 12 June 2025.
11. Web site: Norco (Hydrocodone / Acetaminophen): Basics, Side Effects & Reviews . GoodRX . June 26, 2025 .
12. Web site: Norco vs. Lortab: Difference in Hydrocodone medications . The Recovery Village: Rehabilitation for Mental Health Improvements . 2025-07-07.
13. Web site: Hyloris announces U.S. FDA Approval of Maxigesic® IV . 18 October 2023 .
14. Web site: Paxlovid (nirmatrelvir tablets; ritonavir tablets) for HCPs . 2025-04-24 . paxlovid.pfizerpro.com . en.
15. Web site: Promethazine (CHEBI:8461) .
16. Web site: Rondec (Carbinoxamine Maleate and Pseudoephedrine HCl): Side Effects, Uses, Dosage, Interactions, Warnings . 2025-04-24 . RxList . en.
17. Web site: Diversion Control Division CMEA (The Combat Methamphetamine Epidemic Act of 2005) . 2025-04-24 . www.deadiversion.usdoj.gov.
18. Web site: Anacin: asprin and caffeine tablet . National Institutes Of Health . DailyMed . 2020 . May 28, 2025.
19. Web site: Aspirin and Dual Antiplatement Therapy . American Heart Association (AHA) . Journal of the American Heart Association . April 26, 2025.
20. Web site: Label: Coricidin HBP Cold and Flu . . December 30, 2021.
21. Web site: Chlorpheniramine and Phenylpropanolamine Drug Information - Indications, Dosage, Side Effects and Precautions . 2025-04-15 . Medindia . en-US.
22. Web site: Elvis Presley-Owned Prescription Bottle and Box (1976) . entertainment.ha.com.
23. Web site: JoDrugs. Vernate . 2025-04-24 . www.jodrugs.com.
24. Web site: Dimenhydrinate . 31643540 . 2012 . National Institute of Diabetes and Digestive and Kidney Diseases .
25. https://www.ebi.ac.uk/chebi/searchId.do?chebiId=8461 "The anti-emetic action of both the hydrochloride and the teoclate (8-chlorotheophylline) salts is used for the prevention of nausea in cases of motion sickness and post-operative vomiting."
26. Web site: Esbelcaps (International database) . 2025-04-24 . Drugs.com . en.
27. Web site: Duexis: Uses, Dosage & Side Effects . 2025-04-24 . Drugs.com . en.
28. Web site: Aleve® Pm .
29. Web site: Oxomemazine .
30. Web site: Michael Haichin . Psychedelics Drug Development Tracker . Psychedelic Alpha . 2024 . 29 January 2025.
31. Web site: Minnesota Rules 2002 – Chapter 6800 – Board of Pharmacy – Pharmacy and Pharmacists . www.revisor.mn.gov.
32. Index to Volume V . Journal of J.J. Group of Hospitals and Grant . 1960 . 5 . N/A . 94 . June 26, 2025 . Editorial Board of the Journal of J.J. Group of Hospitals & Grant Medical College.
33. Prescription Pad: Hospital Topics -- ETHOBRAL . Hospital Topics . 1954 . 32 . 2 . 5–6 . 10.1080/00185868.1954.9951807 . June 27, 2025. subscription .
34. Web site: Winston Pharmaceutical products . JO Drug Database . JO Drug Bank . 2025-05-09.
35. News: Kolata . Gina . 1997-09-23 . How Fen-Phen, A Diet 'Miracle,' Rose and Fell . 2025-04-24 . The New York Times . en-US . 0362-4331.
36. News: Schmeck, Jr. . Harold . Curbs Placed on Appetite Suppressants . May 6, 2025 . New York Times . June 15, 1973.
37. Web site: Bontril Timed #1 by CARNRICK Laboratories. JODrugs.
38. Web site: Irwin Neisler & Co. File - File, Nail Science History Institute . 2025-04-24 . sciencehistory.pastperfectonline.com.
39. Web site: Pharmacy Drugstore Obotan Forte Dextroamphetamine Tannate Mallinckrodt . 2025-04-24 . Worthpoint . en.
40. https://pubchem.ncbi.nlm.nih.gov/compound/Dextroamphetamine-tannate chemical name of dexamfetamine tannate
41. Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 368
42. Encyclopedia of international pharmaceutical registrations . Vietnamese National University Encyclopedia of Medicine . 2009 . 4132 . 2025-05-09 . Vietname National U.
43. Green . Aronson . Haddad . A. Richard . Jeffrey K . Peter M . Examining the 'psychopharmacology revolution' (1950–1980) through the advertising of psychoactive drugs in the British Medical Journal . Sage Journal of Psychopharmacology. . 2013 . 32 . 10 . 1056–1066 . 10.1177/0269881118796810 . 30251594 . April 30, 2025. subscription .
44. Bartholomew . Arthur Allen (A.A.) . Amphetamine addiction . Medical Journal of Australia . 1970 . 1 . 24 . 1209–1214 . 10.5694/j.1326-5377.1970.tb84529.x . 5451397 .
45. Mitra. Amitava. Wu. Yunhui. 2012. Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products. The AAPS Journal. 14. 3. 646–655. 10.1208/s12248-012-9378-x.
46. Web site: Cocaine Laced With Veterinary Drug Levamisole Eats Away at Flesh . ABC News.
47. News: Punishing Pill Mill Doctors . William & Mary Press . 2018.
48. Web site: Xylazine: What Clinicians Need to know . New York State Department of Health.
49. Web site: Diversion Control Division . Xylazine .
50. https://www.cfsre.org/images/content/reports/public_alerts/Public-Alert_Bromazolam_NPS-Discovery_061522.pdf Public Alert on Bromazolam and Fentanyl
51. Web site: Xylazine: What Clinicians Need to know . New York State Department of Health.
52. Web site: Diversion Control Division . Xylazine . 2025-04-24.